Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Machine learning-based prediction of subjective cognitive impairment levels in cancer survivors using demographic predictors.

Created on 11 Aug 2026

Authors

Ali Jafarian, Fatemeh Keshmiri Nasrabadi, Mehrshad Khosraviani

Published in

Applied neuropsychology. Adult. Pages 1-7. Aug 10, 2026. Epub Aug 10, 2026.

Abstract

Cancer-related cognitive impairment is a decline in cognitive functioning following cancer treatment that negatively affects survivors' quality of life. Self-report tools such as the Cognitive Failure Questionnaire (CFQ) offer a rapid and cost-effective method for early detection of subjective cognitive difficulties. This study aimed to develop and compare machine learning models using demographic variables to classify subjective cognitive impairment (SCI) severity into low, moderate, and high levels.
Data from 437 cancer survivors were analyzed. SCI severity was defined based on self-reported CFQ scores. Demographic predictors included age, gender, marital status, education, and occupation. Four supervised machine learning algorithms, Logistic Regression (LR), Support Vector Machine (SVM), Artificial Neural Network (ANN), and k-Nearest Neighbors (KNN), were applied for multiclass classification. Model performance was evaluated using accuracy, sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), F1-score and area under the ROC curve (AUC), with stratified 5-fold cross-validation.
LR model demonstrated the best performance (accuracy = 0.89, AUC = 0.95), followed by SVM (accuracy = 0.86, AUC = 0.95), ANN (accuracy = 0.85, AUC = 0.93), and KNN (accuracy = 0.82, AUC = 0.91).
Logistic Regression provided the most robust and interpretable results. These findings support the utility of simple demographic-based models as noninvasive tools that may support early supportive screening of subjective cognitive difficulties in cancer survivorship care. However, external validation using independent datasets is required.

PMID:
42574209
Bibliographic data and abstract were imported from PubMed on 11 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 2
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement